myocardial viability study
Imaging assessment to determine whether dysfunctional myocardium contains viable tissue that could benefit from revascularization.
Full Definition
A comprehensive cardiac imaging evaluation designed to distinguish between viable but hibernating myocardium and irreversibly scarred tissue in patients with coronary artery disease and left ventricular dysfunction. These studies typically employ techniques such as dobutamine stress echocardiography, cardiac MRI with delayed gadolinium enhancement, or nuclear imaging (PET or SPECT) to assess metabolic activity, contractile reserve, and tissue characteristics. The primary clinical application is determining which patients with ischemic cardiomyopathy would benefit from surgical revascularization versus medical therapy or cardiac transplantation. Viable myocardium demonstrates preserved metabolic activity and potential for functional recovery following revascularization, while non-viable tissue shows transmural scarring and will not improve with bypass surgery. Results significantly influence surgical decision-making and patient selection for high-risk revascularization procedures.
Usage
Usage note: Specify the imaging modality used (PET, MRI, dobutamine echo) when referencing viability studies.
In Context
- "The myocardial viability study demonstrated extensive viable tissue in the anterior wall, supporting the decision for surgical revascularization." — preoperative cardiac evaluation
- "PET viability study showed predominantly scar tissue, leading to consideration of heart transplantation over bypass surgery." — cardiac conference notes